L-type Ca2+ channel blockers inhibit the window contraction of mouse aorta segments with high affinity
Cédéric F Michiels1, Cor E Van Hove2, Wim Martinet1
1Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Insights
L-type calcium channel blockers (LCCBs) effectively inhibit non-inactivating calcium channels, contributing to their anti-hypertensive effects. These blockers preferentially target vascular smooth muscle, reducing blood pressure by blocking crucial calcium influx.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Molecular Biology
Background:
- L-type calcium channel blockers (LCCBs) are more effective in hypertensive individuals and vascular smooth muscle (VSM) than normotensive subjects or cardiac muscle.
- This differential efficacy is attributed to the depolarized resting potential in VSM and hypertension, favoring the high-affinity inactivated state of L-type calcium channels (LCCs).
- However, depolarized potentials also increase Ca(2+) influx through window, non-inactivating LCCs.
Purpose of the Study:
- To investigate the efficacy of nifedipine, verapamil, and diltiazem in blocking window, non-inactivating LCCs.
- To elucidate the role of these channels in VSM contractions and their sensitivity to LCCBs.
Main Methods:
- C57Bl6 mouse aortic segments were depolarized using 50mM K(+) to induce inactivation.
- Biphasic contractions were analyzed, and the sensitivity of fast and slow force components to LCCBs was assessed.
- The effects of removing the fast force component and stimulating Ca(2+) influx with BAY K8644 on LCCB efficacy were examined.
Main Results:
- Depolarization evoked biphasic contractions, with the slow force component showing higher sensitivity to LCCBs.
- Removal of the fast force component enhanced LCCB efficacy, while BAY K8644 decreased it.
- LCCBs induced concentration-dependent relaxation, independent of the fast force component, but with reduced sensitivity when BAY K8644 was present.
Conclusions:
- Steady-state contractions induced by 50mM K(+) depolarization are primarily mediated by window Ca(2+) influx, which is effectively inhibited by LCCBs.
- Interactions between LCCB receptors, Ca(2+) ions, and BAY K8644 influence LCCB efficacy.
- The high affinity of LCCBs for open, non-inactivating LCCs likely plays a significant role in their anti-hypertensive actions.
Abstract:
L-type calcium channel blockers (LCCBs) reduce blood pressure more effectively in hypertensive than in normotensive subjects and are more effective in vascular smooth muscle (VSM) than in cardiac muscle. This has been explained by the depolarized resting potential of VSM in comparison with heart muscle cells and during hypertension, because both favor the "high affinity" inactivated state of the L-type calcium channel (LCC). Depolarized resting potentials, however, also increase Ca(2+) influx via window, non-inactivating LCC. The present study investigated whether these channels can be effectively blocked by nifedipine, verapamil or diltiazem, as representatives of different LCCB classes. C57Bl6 mouse aortic segments were depolarized by 50mM K(+) to attain similar degree of inactivation. The depolarization evoked biphasic contractions with the slow force component displaying higher sensitivity to LCCBs than the fast component. Removal of the fast force component increased, whereas stimulation of Ca(2+) influx with the dihydropyridine BAY K8644, a structural analog of nifedipine, decreased the efficacy of the LCCBs. Addition of LCCBs during the contraction caused concentration-dependent relaxation, which was independent of the presence of a fast force component, but still showed lower sensitivity in the presence of BAY K8644. Our data suggest that steady-state contractions by depolarization with 50mM K(+) are completely due to window Ca(2+) influx, which is preferentially inhibited by LCCBs. Furthermore, results point to interactions between the LCCB receptors and Ca(2+) ions or BAY K8644. The high affinity for open, non-inactivating LCC may play a dominant role in the anti-hypertensive effects of LCCBs.
More Related Videos
09:45Simultaneous Measurements of Intracellular Calcium and Membrane Potential in Freshly Isolated and Intact Mouse Cerebral Endothelium
Published on: January 20, 2019
06:22Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current
Published on: November 3, 2020
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
